Evidence map›Paper›PMID 32660438›Full record

ArticleBMC geriatrics2020

The diagnostic value of the Short Physical Performance Battery for sarcopenia.

Steven Phu, Ben Kirk, Ebrahim Bani Hassan, Sara Vogrin, Jesse Zanker, Solange Bernardo, Gustavo Duque

3 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in BMC geriatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06094413 nacompletednot on this mapstarted 2024, after this paper: background citation

The Effects of an 8-week Multicomponent Training Program on Quality of Life, Fear of Falling, &Amp; Physical Performance in Community-Dwelling Older Adults

TypeinterventionalSponsorGeisinger ClinicRan2024 to 2024Enrolled20ConditionsSarcopeniaArmsMulticomponent Training Intervention
NCT06190977 nacompletednot on this mapstarted 2024, after this paper: background citation

Effects of the Otago Exercise Program on Rehabilitation Outcomes of Balance, Strength and Functional Outcomes in Post-Operative Total Knee Replacement Patients

TypeinterventionalSponsorRiphah International UniversityRan2024 to 2025Enrolled44ConditionsTotal Knee ReplacementArmsOtago Exercise Program, General TKR pprotocol
NCT07208916 narecruitingnot on this mapstarted 2025, after this paper: background citation

Evaluation of Grape Consumption to Improve Muscle Strength and Cognitive Function

TypeinterventionalSponsorWestern New England UniversityRan2025 to 2026Enrolled35ConditionsHealthyArmsGrape Powder
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Temporalis muscle biomarkers from routine brain MRI and risk of dementia in two independent cohorts.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Steven PhuAustralian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, Sunshine Hospital, 176 Furlong Road, St Albans, VIC, 3021, Australia.
Ben KirkAustralian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, Sunshine Hospital, 176 Furlong Road, St Albans, VIC, 3021, Australia.
Ebrahim Bani HassanAustralian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, Sunshine Hospital, 176 Furlong Road, St Albans, VIC, 3021, Australia.
Sara VogrinAustralian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, Sunshine Hospital, 176 Furlong Road, St Albans, VIC, 3021, Australia.
Jesse ZankerAustralian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, Sunshine Hospital, 176 Furlong Road, St Albans, VIC, 3021, Australia.
Solange BernardoAustralian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, Sunshine Hospital, 176 Furlong Road, St Albans, VIC, 3021, Australia.
Gustavo DuqueAustralian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, Sunshine Hospital, 176 Furlong Road, St Albans, VIC, 3021, Australia. gustavo.duque@unimelb.edu.au.ORCID 0000-0001-8126-0637
Western Health · AU

Funding

Australian Institute for Musculoskeletal Science (AIMSS) N/A
6 · The paper itself

Abstract

backgroundSarcopenia is defined as the age-related loss of muscle mass, strength, and physical performance. The original European Working Group on Sarcopenia in Older Persons (EWGSOP1) definition, and its revision (EWGSOP2), provide new cut-points and alternate measures for sarcopenia diagnosis. However, sarcopenia is rarely diagnosed in clinical settings owing to its labor-intensive diagnostic process. Given the Short Physical Performance Battery (SPPB) is a quick, easily administrable, and objective measure of muscle strength and physical performance, both of which are key components of sarcopenia, this study examined the diagnostic value of the SPPB for this muscle disease.

methodsA cross-sectional analysis of 294 community-dwelling older persons (≥65 years) was conducted. Appendicular lean body mass [(ALM) divided by height squared (ALM/h

resultsPrevalence of sarcopenia ranged from 4 to 16% depending on the definition. The SPPB demonstrated moderate (AUC = 0.644-0.770) value in diagnosing sarcopenia, and a cut-point of ≤8points in SPPB performance resulted in high sensitivity (82-100%) but low specificity (36-41%) for diagnosing those with severe sarcopenia.

conclusionsThe SPPB displayed acceptable value in diagnosing older adults with severe sarcopenia. Moreover, the high sensitivity of the SPPB when using the cut-point of ≤8 suggests it may be a favorable screening tool for sarcopenia in clinical settings where ALM measurements are not available.

Indexed as

SarcopeniaAgedAged, 80 and overCross-Sectional StudiesHand StrengthHumansMuscle StrengthPhysical Functional PerformanceAgeingDiagnosisSarcopeniaShort physical performance battery

Identifiers

PMID32660438
PMCPMC7359583
OpenAlexW3040807789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.